Georg E. Winter

6.7k total citations · 3 hit papers
48 papers, 4.3k citations indexed

About

Georg E. Winter is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Georg E. Winter has authored 48 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Georg E. Winter's work include Protein Degradation and Inhibitors (29 papers), Ubiquitin and proteasome pathways (20 papers) and Histone Deacetylase Inhibitors Research (6 papers). Georg E. Winter is often cited by papers focused on Protein Degradation and Inhibitors (29 papers), Ubiquitin and proteasome pathways (20 papers) and Histone Deacetylase Inhibitors Research (6 papers). Georg E. Winter collaborates with scholars based in Austria, United States and Germany. Georg E. Winter's co-authors include James E. Bradner, Joshiawa Paulk, Justin M. Roberts, Amanda Souza, Sirano Dhe‐Paganon, Dennis L. Buckley, Giulio Superti‐Furga, Manuele Rebsamen, Berend Snijder and Brent R. Stockwell and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Georg E. Winter

47 papers receiving 4.2k citations

Hit Papers

Phthalimide conjugation as a strategy for in vivo target ... 2015 2026 2018 2022 2015 2015 2025 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg E. Winter Austria 24 3.6k 1.1k 759 666 624 48 4.3k
Kimberly Stegmaier United States 38 3.6k 1.0× 1.0k 1.0× 679 0.9× 757 1.1× 1.2k 2.0× 135 5.4k
Nicholas Kwiatkowski United States 31 3.2k 0.9× 1.5k 1.4× 599 0.8× 241 0.4× 393 0.6× 48 3.9k
Ricardo M. Attar United States 30 1.7k 0.5× 877 0.8× 827 1.1× 652 1.0× 269 0.4× 72 3.2k
Caterina Nardella United States 19 3.1k 0.9× 1.2k 1.1× 896 1.2× 864 1.3× 155 0.2× 26 4.2k
Emma Shtivelman United States 33 2.4k 0.7× 931 0.9× 261 0.3× 602 0.9× 1.4k 2.2× 42 4.2k
Kathryn Packman United States 28 2.6k 0.7× 2.2k 2.0× 481 0.6× 484 0.7× 302 0.5× 65 3.9k
Poulikos I. Poulikakos United States 27 4.7k 1.3× 2.2k 2.0× 670 0.9× 719 1.1× 207 0.3× 46 6.0k
Ayana Sawai United States 9 2.7k 0.7× 1.1k 1.0× 539 0.7× 335 0.5× 99 0.2× 10 3.3k
Loredana Cleris Italy 27 1.5k 0.4× 543 0.5× 227 0.3× 325 0.5× 622 1.0× 54 2.5k
Caroline A. Heckman Finland 31 2.2k 0.6× 993 0.9× 229 0.3× 662 1.0× 822 1.3× 135 3.6k

Countries citing papers authored by Georg E. Winter

Since Specialization
Citations

This map shows the geographic impact of Georg E. Winter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg E. Winter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg E. Winter more than expected).

Fields of papers citing papers by Georg E. Winter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg E. Winter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg E. Winter. The network helps show where Georg E. Winter may publish in the future.

Co-authorship network of co-authors of Georg E. Winter

This figure shows the co-authorship network connecting the top 25 collaborators of Georg E. Winter. A scholar is included among the top collaborators of Georg E. Winter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg E. Winter. Georg E. Winter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hinterndorfer, Matthias, et al.. (2025). Targeted protein degradation for cancer therapy. Nature reviews. Cancer. 25(7). 493–516. 27 indexed citations breakdown →
2.
Schrempf, Anna, et al.. (2024). Degradome analysis to identify direct protein substrates of small-molecule degraders. Cell chemical biology. 32(1). 192–200.e6. 6 indexed citations
3.
Depta, Laura, Marko Cigler, Julien Barbier, et al.. (2024). Inhibition of OSBP blocks retrograde trafficking by inducing partial Golgi degradation. Nature Chemical Biology. 21(2). 203–214. 6 indexed citations
4.
Xie, Jianing, Matthias Hinterndorfer, Marko Cigler, et al.. (2023). Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype. Nature Communications. 14(1). 7908–7908. 23 indexed citations
5.
Colas, Claire, Anna Koren, Fabian Offensperger, et al.. (2023). Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors. Cell chemical biology. 30(8). 953–964.e9. 4 indexed citations
6.
Kozicka, Zuzanna, Dakota J. Suchyta, Georg Kempf, et al.. (2023). Design principles for cyclin K molecular glue degraders. Nature Chemical Biology. 20(1). 93–102. 54 indexed citations
7.
Pous, Joan, Carolina Sánchez, Marko Cigler, et al.. (2023). Discovery and Mechanistic Elucidation of NQO1‐Bioactivatable Small Molecules That Overcome Resistance to Degraders. Angewandte Chemie. 136(12). 2 indexed citations
8.
Winter, Georg E. & Cristina Mayor‐Ruiz. (2023). Proximity-inducing pharmacology. Nature Chemical Biology. 20(1). 13–14. 1 indexed citations
9.
Siklos, Marton I., Jan Borggräfe, Anna Koren, et al.. (2023). Pharmacological perturbation of the phase-separating protein SMNDC1. Nature Communications. 14(1). 4504–4504. 9 indexed citations
10.
Schrempf, Anna, Dominik Kirchhofer, Gerald Timelthaler, et al.. (2022). POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells. Cell Reports. 41(9). 111716–111716. 47 indexed citations
11.
Jaeger, Martin G., Björn Schwalb, Sebastian D. Mackowiak, et al.. (2020). Selective Mediator dependence of cell-type-specifying transcription. Nature Genetics. 52(7). 719–727. 92 indexed citations
12.
Berger, Martin, et al.. (2020). Application of Relay C−H Oxidation Logic to Polyhydroxylated Oleanane Triterpenoids. Chem. 6(5). 1183–1189. 22 indexed citations
13.
Hanzl, Alexander & Georg E. Winter. (2020). Targeted protein degradation: current and future challenges. Current Opinion in Chemical Biology. 56. 35–41. 95 indexed citations
14.
Mayor‐Ruiz, Cristina, Martin G. Jaeger, Sophie Bauer, et al.. (2019). Plasticity of the Cullin-RING Ligase Repertoire Shapes Sensitivity to Ligand-Induced Protein Degradation. Molecular Cell. 75(4). 849–858.e8. 73 indexed citations
15.
Zeid, Rhamy, Matthew A. Lawlor, Evon Poon, et al.. (2018). Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nature Genetics. 50(4). 515–523. 129 indexed citations
16.
Radic-Sarikas, Branka, Melinda Halász, K. Huber, et al.. (2017). Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter. Scientific Reports. 7(1). 3091–3091. 24 indexed citations
17.
Winter, Georg E., Dennis L. Buckley, Joshiawa Paulk, et al.. (2015). Phthalimide conjugation as a strategy for in vivo target protein degradation. Science. 348(6241). 1376–1381. 1253 indexed citations breakdown →
18.
Borgdorff, Viola, Uwe Rix, Georg E. Winter, et al.. (2013). A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF. Oncogene. 33(19). 2531–2539. 26 indexed citations
19.
Ubaida‐Mohien, Ceereena, Jürgen Hartler, Florian P. Breitwieser, et al.. (2010). MASPECTRAS 2: An integration and analysis platform for proteomic data. PROTEOMICS. 10(14). 2719–2722. 18 indexed citations
20.
Pedley, RB, et al.. (1999). Tumour targeting using MFE-23 :: TNF alpha fusion protein.. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026